Resumen de Lifespan

In *Lifespan: Why We Age—and Why We Don't Have To*, Harvard geneticist David A. Sinclair argues that aging is not an inevitable decline but a treatable disease driven by a loss of epigenetic information. Central to the book is the "Information Theory of Aging," which holds that DNA itself remains largely intact while the epigenetic "reader" that tells cells which genes to use degrades over time. Sinclair introduces the concept of the "Hallmarks of Aging," a set of biological mechanisms including genomic instability, telomere attrition, and mitochondrial dysfunction, and describes experiments in his lab and others showing these can be slowed or reversed in yeast, mice, and human cells. He highlights the roles of sirtuins, NAD+ depletion, and cellular reprogramming, drawing on research into caloric restriction, rapamycin, metformin, and resveratrol. The book also presents the "Survival Circuit," an evolved set of defenses that can be activated by stressors such as fasting, cold, and exercise. Two chapter-based ideas recur: the "longevity genes" and the notion of an "epigenetic clock" that measures biological rather than chronological age. Sinclair discusses the "Yamanaka factors" and his lab's work on reversing vision loss in mice, framing such feats as proof that aging is plastic. A recurring protagonist is Sinclair's own scientific career, from his early yeast studies to his advocacy, alongside figures like Leonard Guarente and Cynthia Kenyon. The book's final section shifts to ethics and society, proposing that extending healthspan could reshape medicine, the economy, and population policy. Sinclair closes with a personal regimen and a cautious optimism that future therapies might add decades of healthy life, while acknowledging unresolved debates and the need for clinical trials.